Energizer exec steps down
This article was originally published in The Rose Sheet
Executive SummaryPresident Pat Mannix will retire from Energizer, effective March 31, 2004, firm announces. Mannix' 40-year tenure at Energizer began at the Eveready Battery Company in Sydney, Australia in 1963. Mannix was appointed president of Energizer in March 2001 after the company was spun off from Ralston Purina. Energizer has not yet named a successor, according to the firm...
You may also be interested in...
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced January 2020.
Industry experts expect a continued uptick in deals valued between $2bn-$10bn this year as buyers look to add critical mass in areas like oncology, rare disease and cell and gene therapy. Divestitures to free up capital and narrow focus should continue too.
UK-centric investment firm Syncona’s model of “founding, building and funding” early-stage biotech companies – with a commitment to the longer term – hopes to help make Great Britain a cell and gene therapy powerhouse.